Medifast, Inc. (MED)

NYSE • Currently up 0.08 (+0.63%) in today's trading session

2 members of Congress have disclosed 20 trades in Medifast, Inc. (MED) via STOCK Act filings. The most recent disclosure was a sale by Paul Mitchell on 6 March 2020. The most active traders have been Paul Mitchell (16) and Donna E. Shalala (4). Aggregate disclosed activity totals roughly $3.9M in purchases and $6.2M in sales (midpoint estimates from bracketed disclosure amounts).

Medifast, Inc. is currently trading at $12.81, positioned at 85% of its 52-week range ($9.22 – $13.45).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$12.81
24h Change
+0.08 (+0.63%)
52 Week Range
$9.22–$13.45
View on NASDAQ

Medifast, Inc. Price History and Technical Analysis

Congressional Trading Activity for MED

Select to highlight on chart
5 transactions
Compliance: 10%
Paul Mitchell6 Mar 202019 Jan 2021SaleStock$50,001 - $100,000N/A
Paul Mitchell6 Mar 202019 Jan 2021SaleStock$50,001 - $100,000N/A
Paul Mitchell5 Mar 202019 Jan 2021SaleStock$1,000,001 - $5,000,000N/A
Paul Mitchell5 Mar 202019 Jan 2021SaleStock$1,000,001 - $5,000,000N/A
Paul Mitchell8 Nov 20195 Aug 2020PurchaseStock$500,001 - $1,000,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$143.25M

Volume

89.71K

Beta

0.69

P/E Ratio

-10.41

Fundamentals

EPS

$-1.23

Div. Yield

-

Open

$12.64

Day Range

$12.64 – $12.94

Company Information

Sector
Consumer Cyclical
Industry
Personal Products & Services
Exchange
NYSE · USD
Country
US
CEO
Nicholas Johnson
IPO Date
1993-12-30

Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the...

Earnings

Next Report

Q4 2026

16 Feb

EPS Est.

$0.01

Rev. Est.

$64.1M

Days Until

99

Recent Quarters

Q3 202626 Oct
EPS$-0.19
Beat 45.7%
Q2 20263 Aug
EPS$-0.28
Beat 56.9%
Q1 20264 May
EPS$-0.19
Beat 65.5%
Q4 202517 Feb
EPS$-0.55
Beat 27.6%
Q3 20253 Nov
EPS$-0.21
Miss 2000.0%
Q2 20254 Aug
EPS$0.23
Beat 221.1%
Q1 202528 Apr
EPS$-0.11
Beat 56.0%
Q4 202418 Feb
EPS$0.10
Beat 162.5%
Q3 20244 Nov
EPS$0.35
Beat 333.3%
Q2 20245 Aug
EPS$0.92
Beat 155.6%
Q1 202429 Apr
EPS$0.66
Miss 15.4%
Q4 202320 Feb
EPS$1.09
Beat 10.1%
Q3 20236 Nov
EPS$2.12
Beat 98.1%
Q2 20237 Aug
EPS$2.77
Beat 92.4%
Q1 20231 May
EPS$3.67
Beat 52.9%
Q4 202221 Feb
EPS$3.70
Beat 69.7%
Q3 20223 Nov
EPS$3.27
Beat 71.2%
Q2 20223 Aug
EPS$3.42
Beat 5.9%
Q1 20222 May
EPS$3.59
Beat 0.6%
Q4 202123 Feb
EPS$2.91
Beat 9.8%
Q3 20214 Nov
EPS$3.56
Beat 15.6%
Q2 20214 Aug
EPS$3.96
Beat 19.3%
Q1 20214 May
EPS$3.46
Beat 26.7%
Q4 202025 Feb
EPS$2.36
Miss 0.8%
Q3 20202 Nov
EPS$2.91
Beat 18.3%
Q2 20205 Aug
EPS$1.96
Beat 7.1%
Q1 20205 May
EPS$1.93
Beat 45.1%
Q4 201926 Feb
EPS$1.19
Beat 11.2%
Q3 20197 Nov
EPS$1.32
Miss 1.5%
Q2 20191 Aug
EPS$1.75
Beat 1.7%
Q1 20191 May
EPS$1.70
Beat 10.4%
Q4 201826 Feb
EPS$1.30
Beat 7.4%
Q3 20186 Nov
EPS$1.14
Beat 0.0%
Q2 20182 Aug
EPS$1.16
Beat 16.0%
Q1 20183 May
EPS$1.01
Beat 17.4%
Q4 20176 Mar
EPS$0.60
Beat 25.0%
Q3 20177 Nov
EPS$0.55
Beat 7.8%
Q2 20178 Aug
EPS$0.63
Beat 21.1%
Q1 20174 May
EPS$0.51
Beat 8.5%
Q4 20169 Mar
EPS$0.34
Beat 3.0%
Q3 20163 Nov
EPS$0.51
Beat 13.3%
Q2 20163 Aug
EPS$0.63
Beat 26.0%
Q1 20164 May
EPS$0.42
Beat 27.3%
Q4 201510 Mar
EPS$0.33
Miss 5.7%
Q3 20155 Nov
EPS$0.45
Beat 7.1%
Q2 20155 Aug
EPS$0.48
Beat 0.0%
Q1 20157 May
EPS$0.46
Beat 31.4%
Q4 201412 Mar
EPS$0.38
Miss 17.4%
Q3 20145 Nov
EPS$0.39
Beat 8.3%
Q2 20147 Aug
EPS$0.44
Beat 12.8%
Q1 20145 May
EPS$0.45
Beat 25.0%
Q4 201310 Mar
EPS$0.39
Beat 8.3%
Q3 20135 Nov
EPS$0.41
Miss 2.4%
Q2 20136 Aug
EPS$0.51
Beat 0.0%
Q1 20138 May
EPS$0.43
Beat 26.5%
Q4 20127 Mar
EPS$0.28
Beat 12.0%
Q3 20125 Nov
EPS$0.42
Beat 5.0%
Q2 201226 Jul
EPS$0.46
Beat 24.3%
Q1 20128 May
EPS$0.32
Miss 13.5%
Q4 201113 Mar
EPS$0.09
Miss 57.1%
Q3 20113 Nov
EPS$0.36
Miss 2.7%
Q2 20114 Aug
EPS$0.41
Miss 12.8%
Q1 201110 May
EPS$0.44
Q1 20119 May
EPS$0.44
Beat 7.3%
Q3 20104 Nov
EPS$0.39
Beat 0.0%
Q2 20105 Aug
EPS$0.38
Beat 11.8%
Q1 20105 May
EPS$0.33
Beat 22.2%
Q4 20094 Mar
EPS$0.21
Beat 10.5%
Q3 200929 Oct
EPS$0.23
Beat 21.1%
Q2 200930 Jul
EPS$0.20
Beat 17.6%
Q1 200929 Apr
EPS$0.17
Beat 41.7%
Q4 200812 Mar
EPS$0.07
Miss 12.5%
Q3 20086 Nov
EPS$0.11
Beat 0.0%
Q2 20087 Aug
EPS$0.11
Beat 22.2%
Q1 200812 May
EPS$0.10
Miss 9.1%
Q4 200712 Mar
EPS$0.04
Miss 33.3%
Q3 20078 Nov
EPS$0.07
Miss 12.5%
Q2 20079 Aug
EPS$0.07
Miss 30.0%
Q1 200710 May
EPS$0.10
Miss 28.6%
Q4 200616 Mar
EPS$0.03
Miss 40.0%
Q3 200614 Nov
EPS$0.11
Beat 22.2%
Q2 200614 Aug
EPS$0.11
Beat 0.0%
Q1 200615 May
EPS$0.13
Beat 85.7%
Q4 200515 Mar
EPS$0.07
Beat 133.3%
Q3 20059 Nov
EPS$0.05
Beat 25.0%
Q2 20059 Aug
EPS$0.06
Beat 0.0%
Q1 200510 May
EPS$0.04
Miss 20.0%
Q4 200414 Mar
EPS$0.04
Beat 33.3%
Q3 200415 Nov
EPS$0.03
Miss 50.0%
Q2 200416 Aug
EPS$0.06
Beat 20.0%
Q1 200412 May
EPS$0.05
Beat 0.0%
Q4 200315 Mar
EPS$0.04
Beat 33.3%
Q3 200313 Nov
EPS$0.04
Miss 33.3%
Q2 200314 Aug
EPS$0.05
Miss 37.5%
Q1 20035 May
EPS$0.08
Beat 33.3%
Q3 20024 Nov
EPS$0.18
Q2 200225 Jul
EPS$0.08
Q1 20022 May
EPS$0.03
Q4 20018 Mar
EPS$0.00
Q3 200131 Oct
EPS$0.02
Q2 200126 Jul
EPS$0.02
Q1 200114 May
EPS$0.03
Q4 200029 Mar
EPS$0.09
Q3 200030 Oct
EPS$0.03
Q2 200011 Aug
EPS$0.04
Q1 200015 May
EPS$0.05
Q1 200010 Apr
EPS$0.03
Q3 199915 Nov
EPS$-0.31
Q2 199916 Aug
EPS$-0.17
Q1 199917 May
EPS$-0.14
Q1 199915 Apr
EPS$-0.14
Q3 199810 Nov
EPS$0.10
Q1 199815 May
EPS$-0.16
Q1 199815 Apr
EPS$-0.63
Q3 199714 Nov
EPS$-0.14
Q2 199713 Aug
EPS$-0.05
Q1 199714 May
EPS$-0.05
Q1 19978 Apr
EPS$0.02
Q3 199613 Nov
EPS$0.05

2 politicians traded within 30 days

Dividends

Dividend History

18 Sept 2023
Amount $1.6500
26 Jun 2023
Amount $1.6500
27 Mar 2023
Amount $1.6500
19 Dec 2022
Amount $1.6400
19 Sept 2022
Amount $1.6400
27 Jun 2022
Amount $1.6400
28 Mar 2022
Amount $1.6400
20 Dec 2021
Amount $1.4200
20 Sept 2021
Amount $1.4200
21 Jun 2021
Amount $1.4200
29 Mar 2021
Amount $1.4200
21 Dec 2020
Amount $1.1300
21 Sept 2020
Amount $1.1300
29 Jun 2020
Amount $1.1300
30 Mar 2020
Amount $1.1300
26 Dec 2019
Amount $1.1300
26 Sept 2019
Amount $0.7500
27 Jun 2019
Amount $0.7500
28 Mar 2019
Amount $0.7500
20 Dec 2018
Amount $0.7500
20 Sept 2018
Amount $0.4800
28 Jun 2018
Amount $0.4800
28 Mar 2018
Amount $0.4800
21 Dec 2017
Amount $0.4800
21 Sept 2017
Amount $0.3200
21 Jun 2017
Amount $0.3200
21 Mar 2017
Amount $0.3200
21 Dec 2016
Amount $0.3200
21 Sept 2016
Amount $0.2500
23 Jun 2016
Amount $0.2500
17 Mar 2016
Amount $0.2500
23 Dec 2015
Amount $0.2500

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MED

Which members of Congress have traded MED?
2 members of Congress have disclosed 20 trades in Medifast, Inc. (MED) under the STOCK Act. The most active traders are Paul Mitchell and Donna E. Shalala.
When was MED most recently disclosed by Congress?
The most recent MED disclosure was a sale by Paul Mitchell on 6 March 2020.
What is the total disclosed congressional trading volume for MED?
Members of Congress have disclosed approximately $3.9M in MED purchases and $6.2M in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MED?
This MED page updates as soon as new STOCK Act disclosures are filed for Medifast, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.